PDL BIOPHARMA INC (PDLIEUR) Institutional Ownership Changes & 13F Activity
PDL BIOPHARMA INC (PDLIEUR). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2014). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Renaissance Technologies LLC.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Buy | +1,037,570 | +8.7% | 12,896,754 | $124.84M | Q2 2014 | Aug 13, 2014 |
Frequently asked questions about PDLIEUR activity
Which institutional owners are buying PDLIEUR?
Institutional owners buying PDLIEUR include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in PDLIEUR activity?
"Buy" means an investor increased their reported position in PDLIEUR compared to the prior reporting period. This reflects growing exposure to PDL BIOPHARMA INC (PDLIEUR) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in PDLIEUR increasing?
Institutional interest in PDLIEUR can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.